SYROS

What this means for you

Registered since 13 Feb 2018. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

87280336

Registration number

5402972

Mark type

Design + words

Filed

24 Dec 2016

Published for opposition

30 May 2017

Registered

13 Feb 2018

Attorney of record

Nathan T. Harris

Goods and services

• Class 005 — Pharmaceuticals: pharmaceutical preparations and compounds for use in the treatment of cancer; pharmaceutical preparations and compounds for inhibition of transcriptional regulators
• Class 042 — Scientific and technological services: consulting services in the field of pharmaceutical research and development; research and development of pharmaceuticals and compounds for the treatment of cancer; research and development of pharmaceuticals and compounds for inhibition of transcriptional regulators; research and development of pharmaceutical preparations and medicines for others

Owner

• Syros Pharmaceuticals, Inc, Cambridge, MA, US
• Syros Pharmaceuticals, Inc, Cambridge, MA, US
• Syros Pharmaceuticals, Inc, Cambridge, MA, US

Prosecution history

• 26 Nov 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
• 26 Nov 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
• 26 Nov 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 14 Jun 2024 — TEAS SECTION 8 & 15 RECEIVED
• 13 Feb 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
• 17 Jun 2020 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
• 17 Jun 2020 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 17 Jun 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 17 Jun 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 17 Jun 2020 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
• 15 May 2018 — CORRECTION UNDER SECTION 7 - PROCESSED
• 13 Feb 2018 — REGISTERED-PRINCIPAL REGISTER
• 10 Jan 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
• 09 Jan 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
• 19 Dec 2017 — STATEMENT OF USE PROCESSING COMPLETE